Prime Medicine Inc. (PRME)
2.81
0.11 (4.07%)
At close: Jan 15, 2025, 12:51 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -198.13M | -121.82M | -165.37M | -3.41M | -2.53M |
| Depreciation & Amortization | 4.65M | 2.22M | 568.00K | 43.00K | n/a |
| Stock-Based Compensation | 13.91M | 6.46M | 1.75M | 391.00K | n/a |
| Other Working Capital | -6.49M | -37.86M | 29.99M | -86.00K | 492.00K |
| Other Non-Cash Items | 11.79M | 17.68M | 98.42M | -4.60M | 703.00K |
| Deferred Income Tax | -279.00K | -964.00K | -624.00K | 1.87M | n/a |
| Change in Working Capital | 2.65M | -35.40M | 31.18M | 164.00K | 492.00K |
| Operating Cash Flow | -165.41M | -131.83M | -34.08M | -5.54M | -1.33M |
| Capital Expenditures | -8.72M | -16.09M | -4.15M | -639.00K | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -104.95M | -123.34M | -81.98M | n/a | n/a |
| Sales Maturities Of Investments | 132.56M | 93.00M | 13.00M | n/a | n/a |
| Other Investing Acitivies | -170.00K | -665.00K | -496.00K | -423.00K | n/a |
| Investing Cash Flow | 18.71M | -47.10M | -73.63M | -1.06M | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 655.00K | -3.82M | 269.28M | 34.93M | 9.98M |
| Financial Cash Flow | 655.00K | 181.49M | 269.28M | 34.93M | 9.98M |
| Net Cash Flow | -146.05M | 2.57M | 161.57M | 28.33M | 8.65M |
| Free Cash Flow | -174.14M | -147.92M | -38.23M | -6.18M | -1.33M |